XML 21 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 555,320 $ 1,137,303
Trade accounts receivable, less allowance for doubtful accounts (2018—$4,460; 2017—$10,425) 605,712 534,326
Other accounts receivable 52,059 37,937
Inventories 700,540 592,781
Other current assets 84,790 136,064
Assets held for sale 0 39,152
Total current assets 1,998,421 2,477,563
Property, plant and equipment, at cost 4,799,063 4,124,335
Less accumulated depreciation and amortization 1,777,979 1,631,025
Net property, plant and equipment 3,021,084 2,493,310
Investments 528,722 534,064
Noncurrent assets held for sale 0 139,813
Other assets 80,135 74,164
Goodwill 1,567,169 1,610,355
Other intangibles, net of amortization 386,143 421,503
Total assets 7,581,674 7,750,772
Current liabilities:    
Accounts payable 522,516 418,537
Accrued expenses 257,323 268,336
Current portion of long-term debt 307,294 422,012
Dividends payable 35,169 35,165
Liabilities held for sale 0 1,938
Income taxes payable 60,871 54,937
Total current liabilities 1,183,173 1,200,925
Long-term debt 1,397,916 1,415,360
Postretirement benefits 46,157 52,003
Pension benefits 285,396 294,611
Noncurrent liabilities held for sale 0 614
Other noncurrent liabilities 526,942 599,174
Deferred income taxes 382,982 370,389
Commitments and contingencies
Albemarle Corporation shareholders’ equity:    
Common stock, $.01 par value (authorized 150,000 shares), issued and outstanding — 105,616 in 2018 and 110,547 in 2017 1,056 1,105
Additional paid-in capital 1,368,897 1,863,949
Accumulated other comprehensive loss (350,682) (225,668)
Retained earnings 2,566,050 2,035,163
Total Albemarle Corporation shareholders’ equity 3,585,321 3,674,549
Noncontrolling interests 173,787 143,147
Total equity 3,759,108 3,817,696
Total liabilities and equity $ 7,581,674 $ 7,750,772